Helsinn Group Announces Upcoming Presentation of Phase 3b Data of NEPA (fosnetupitant / palonosetron) IV at ASCO 2019
Lugano, Switzerland, May 31 (Korea Bizwire) – Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, today announces that the data on the intravenous (IV) formulation of NEPA (Akynzeo®) will be presented as poster at the American Society of Clinical Oncology (ASCO) Congress in June 2019 on the poster session Symptoms and Survivorship. [...]




![[Feature] Outdoor Market Grows Fast Thanks to Rising Awareness on Exercise [Feature] Outdoor Market Grows Fast Thanks to Rising Awareness on Exercise](http://koreabizwire.com/wp/wp-content/uploads/2014/04/14739481_xl-800x533.jpg)